Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

State of Play for January: Atlas Pipeline Partners, L.P. (APL), Pilgrim’s Pride Corporation (PPC)

Page 1 of 2

With markets toying at all-time highs I have decided to take some money off the table, with the intention of buying into the next dip.  The S&P hasn’t qualified itself as in ‘profit taking’ territory as defined by my Investment Strategy, but a little bit of wiggle room is allowed!  I also think the next dip will not reach the depths I like for a low-risk buy, so it will be a matter of watching the market and looking for opportunities as they appear.

I did close one position I own: Pilgrim’s Pride Corporation (NYSE:PPC) has served me well, and reached the goal I was looking from it.  I did not add to the position on October’s earnings, but the stock did manage to handily beat estimates and report a profit, when it had looked like – to me at least – a big loss was on the cards.  Analysts are looking for a next quarter loss of -$0.11 per share, so it’s not entirely out of the woods.  The company emphasized its improved debt and liquidity position, which gives it some leeway of riding out tough events like this past summer.  An interesting snippet from the conference call was the idea of buying chicken in, rather than growing more chickens.  This would improve margins and better optimize inventory, where prior excesses in chicken production were marketed in its prepared food division.  It would also leave it less exposed to vagaries of feed costs.

Atlas Pipeline Partners, L.P. (NYSE:APL)Pilgrim’s Price sources 10% of its corn needs from South America at “competitive pricing,” and is looking to source an additional 10% from this market to help offset what is sees will be continued high pricing for corn and soybean meal into 2013.  High feed prices have troubled the stock in the past.  The remaining 80% of its feed requirements will be subject to market forces, and the company did note such challenges for the next quarter.  The company had an increased spend of $56 million on feed in the last quarter, but managed to offset the cost in earnings with a 1.4% increase in sales and a strong export market (Mexico in particular, despite avian flu), which helped reduce inventory.  In light of this, Pilgrim’s Pride has doubled in price since I last wrote about it in October.  While it could go higher, a current P/E of 30.5 (compared to an Industry average P/E of 16.3) with a loss expected next quarter means I am happy to take my position off the table for a very handy profit.

The two other stocks I hold from my Fool collection are Atlas Pipeline Partners, L.P. (NYSE:APL) and Freeport-McMoRan Copper & Gold Inc. (NYSE:FCX).  These were featured in March of last year.  I have made around three purchase lots into each, holding Atlas Pipeline at an average of $31.18 a share and Freeport-McMoran Copper at $33.92 a share.  Unfortunately, both stocks trade below their feature price and have significantly underperformed against the larger market.  However, I would still be considered a ‘buyer’ of both stocks, but I think both will trade cheaper in the months ahead.

Freeport McMoRan Copper & Gold Inc. (NYSE:FCX) is the weaker of the two.  The miners, as a group, have suffered inversely to the rise of all other sectors in the S&P.  Freeport McMoran has been somewhat insulated as its primary focus is base metals, but increased pressure on U.S. treasury yields translates to lower commodity prices (priced in dollars) as inflationary risks decline.  The latter trend does not look like ending any time soon. Europe is still struggling, despite aggressive bond buying (sending yields lower there too).  Potential markers for a recovery in the consumer, such as in Housing or Automotive, which would contribute to inflation and higher commodity prices, remain weak.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!